[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome

NCT05017844 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

222

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: KSR-001-04
DRUG: KSR-001-02
DRUG: KSR-001-03

Sponsor

Kukje Pharma

Collaborators

[object Object]